Brain STimulation for ANxiety and Depression in Youth

What this study is about

In this open-label trial, the overall aim is to determine if TMS treatment can improve anxiety and depression in a broad group of children and youth referred by physicians.

Who can join (things the study team will check)

✅ You may be able to join if…

• aged between 6 and 18 years old
• diagnosis of anxiety or depression made by a qualified medical professional
• active anxiety and/or depression symptoms

🚫 You may not be able to join if…

• status epilepticus in past 12-months
• presence of any disease, medical condition, or physical condition that, in the opinion of the study investigator may compromise, interfere, limit, affect, or reduce the participant's ability to complete the study
• hospitalization for suicide attempt within the past 3 months (unless participant is under the daily supervision of a physician, such as in a mental health day treatment program)
• TMS-related contraindications, including implanted medical devices (e.g., pacemaker)
• if actively taking prescription medication, no changes in medication for at least 3 months prior to entry into the study, with no anticipation of change in the frequency or dose over the duration of the study, unless changes to medication are required for participant safety
• unable to understand instructions in English

Where this trial is running

• Alberta Children's Hospital, Calgary, Alberta, Canada

Who to contact

Kara Murias, MD/PhD · 1 403-441-8411 · krmarten@ucalgary.ca

It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT06892847.